Tag: Phase 3 Trial

PainReform, a clinical-stage specialty pharmaceutical company, is set to commence the second part of its phase 3 trial for evaluating ...

FibroGen, a pharmaceutical company, experienced a major drop in its share prices after the announcement of its failed Phase 3 ...